Victory Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,540
Closed -$1.06M 2476
2025
Q4
$1.06M Sell
33,540
-140,245
-81% -$4.65M ﹤0.01% 1804
2025
Q3
$6.2M Buy
173,785
+7,626
+5% +$348K ﹤0.01% 1263
2025
Q2
$9.57M Sell
166,159
-7,682
-4% -$434K 0.01% 1130
2025
Q1
$10.1M Buy
173,841
+20,835
+14% +$1.42M 0.01% 1036
2024
Q4
$12.3M Sell
153,006
-40,179
-21% -$3.43M 0.01% 1017
2024
Q3
$15.5M Sell
193,185
-36,410
-16% -$2.59M 0.01% 942
2024
Q2
$14M Sell
229,595
-10,281
-4% -$611K 0.01% 946
2024
Q1
$11.9M Buy
239,876
+23,840
+11% +$1.13M 0.01% 1012
2023
Q4
$9.05M Sell
216,036
-84,935
-28% -$2.89M 0.01% 1088
2023
Q3
$9.87M Buy
300,971
+6,980
+2% +$238K 0.01% 1021
2023
Q2
$10.4M Buy
293,991
+87,395
+42% +$2.89M 0.01% 1030
2023
Q1
$5.87M Buy
206,596
+43,811
+27% +$1.55M 0.01% 1170
2022
Q4
$6.76M Buy
+162,785
New +$6.99M 0.01% 1135

Other funds holding PRCT

Victory Capital Management's PRCT Position: Q1 2026 in Review

Victory Capital Management sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 33,540 shares — an estimated $1.06M sold.

Victory Capital Management first reported a position in PRCT in Q4 2022 and held it in 13 quarters. The position peaked at $15.5M in Q3 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Victory Capital Management reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Victory Capital Management sold 33,540 Procept Biorobotics shares in Q1 2026, an estimated $1.06M.
  • Victory Capital Management first reported a position in Procept Biorobotics in Q4 2022 and held it in 13 quarters.
  • Victory Capital Management's Procept Biorobotics position peaked at $15.5M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.